Dengue vaccine
Dengue Vaccine
The Dengue Vaccine (pronounced: DEN-guee) is a vaccine used to prevent Dengue fever, a mosquito-borne tropical disease caused by the dengue virus.
Etymology
The term "Dengue" is derived from the Swahili phrase "Ka-dinga pepo", which describes the disease as being caused by an evil spirit. The Spanish mispronounced the phrase as "dengue", leading to the use of the term in the medical field.
Description
The Dengue Vaccine, also known as CYD-TDV and sold under the brand name Dengvaxia, is the first dengue vaccine to be licensed. It was developed by Sanofi Pasteur and first licensed in 2015. The vaccine is given by injection and is recommended by the World Health Organization (WHO) for those who have previously had a dengue infection.
Related Terms
- Dengue fever: A mosquito-borne tropical disease caused by the dengue virus.
- Dengue virus: The virus that causes dengue fever.
- CYD-TDV: The scientific name for the Dengue Vaccine.
- Dengvaxia: The brand name for the Dengue Vaccine.
- Sanofi Pasteur: The pharmaceutical company that developed the Dengue Vaccine.
- World Health Organization: An international organization that provides health-related recommendations, including the use of the Dengue Vaccine.
External links
- Medical encyclopedia article on Dengue vaccine
- Wikipedia's article - Dengue vaccine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski